Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 12Active not recruiting 6Unknown 4Recruiting 3Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 24Neoplasms 4Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Hodgkin Disease 2Sleep Apnea, Obstructive 1Recurrence 1Prostate Adenocarcinoma 1Premenopausal Breast Cancer 1Polycystic Ovary Syndrome 1Myeloproliferative Disorders 1Metabolic Syndrome 1Lymphoma, Mantle-Cell 1Leukemia, Myeloid, Acute 1Leiomyoma 1Insulin Resistance 1Glucose Intolerance 1Breast Neoplasms 1

Interventions

Trastuzumab 78Capecitabine 59Cyclophosphamide 54Paclitaxel 52Docetaxel 50Letrozole 44Fulvestrant 43Lapatinib 34Doxorubicin 31Carboplatin 31Vinorelbine 30Bevacizumab 29Anastrozole 28pembrolizumab 26exemestane 24Tamoxifen 23Gemcitabine 22Radiotherapy 21Albumin-Bound Paclitaxel 19Taxes 17Everolimus 17Epirubicin 15pertuzumab 13Ado-Trastuzumab Emtansine 13130-nm albumin-bound paclitaxel 13palbociclib 12Magnetic Resonance Spectroscopy 12liposomal doxorubicin 11atezolizumab 11Filgrastim 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Breast Neoplasms × Leuprolide × Clear all
NCT00498901 2013-05-09

Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer

University of Washington

Phase 2 Terminated
1 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡